TABLE 1.

Sequences of peptides used

	Sequence	Restriction element	Source	Protein	Position
P1	GILGFVFTL	HLA-A*02:01	Influenza A virus	Matrix protein 1	58–66
P2	NLVPMVATV	HLA-A*02:01	Human cytomegalovirus	Lower matrix phosphoprotein pp65	495–504
P3	FLPSDFFPSI	HLA-A*02:01	Hepatitis B virus (Genotype B)	Core protein	18–27
P4	SVLAFRRL	H-2Kb	Toxoplasma gondii	Tgd057	59–66
P5	SIYRYYGL	H-2Kb	Synthetic superagonist	Synthetic superagonist	NA
P6	SIINFEKL	H-2Kb	Gallus gallus	Ovalbumin	257–264
P7	SAVSNLFYV	H-2Db	Chlamydia trachomatis (Serovar L2)	Polymorphic outer membrane protein	612–620
P8	ASNENMETM	H-2Db	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	Nucleoprotein	366–374
P9	ASFVNPIYL	H-2Db	Chlamydia trachomatis (Serovar L2)	Cysteine-rich membrane protein A	63–71
P10	FLPSDFFPSV	HLA-A*02:01	Hepatitis B virus (Genotype D)	Core Protein	18–27
P11	AVFDRKSDAK	HLA-A*11:01	Human herpesvirus 4 (strain B95-8)	Epstein-Barr nuclear antigen 4	399–408